+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Mirna Sequencing and Assay Market Outlook 2026-2034: by Product (Sequencing Consumables, Library Preparation Kits, Sequencing Platforms / Instruments, Bioinformatics Pipelines & Services), Application, Technology, End User

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6242566
UP TO OFF until Jan 01st 2027
The Mirna Sequencing And Assay Market is estimated at US$413.2 million in 2026 and is projected to grow at a CAGR of 10.1% to reach US$892.2 million by 2034.

Market Overview

The Mirna Sequencing And Assay Market covers sequencing platforms, detection assays, reagents, and analysis tools used to study micro ribonucleic acid expression, function, and biomarker relevance across research and translational workflows.

Core demand comes from oncology studies, biomarker discovery, translational medicine, liquid biopsy research, academic genomics, and companion diagnostic development, where buyers prioritize reliability, performance, and strong workflow or mission fit. Growth is supported by interest in non invasive biomarkers, growth in precision medicine research, and demand for tools that can support earlier and more targeted disease understanding.

Market Segmentation

By Product

  • Sequencing Consumables
  • Library Preparation Kits
  • Sequencing Platforms / Instruments
  • Bioinformatics Pipelines & Services

By Application

  • Oncology Diagnostics / Liquid Biopsy
  • Drug Discovery & Transcriptome Research
  • Other Applications

By Technology

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor
  • SOLiD
  • Nanopore Sequencing
  • Single-Molecule Real-Time (SMRT)

By End User

  • Clinical Laboratories
  • Academic & Research Institutes
  • Biotech / Pharma Companies
  • Contract Research Organizations

Key Companies Analysed

  • Illumina
  • Thermo Fisher Scientific
  • QIAGEN
  • Agilent Technologies
  • Takara Bio
  • Bio-Rad Laboratories
  • PerkinElmer
  • Merck KGaA
  • New England Biolabs
  • Lexogen
  • NanoString Technologies
  • HTG Molecular Diagnostics
  • GenXPro
  • Norgen Biotek
  • Abcam
  • Promega
  • OriGene
  • LGC Biosearch Technologies
  • System Biosciences
  • BioVendor

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Mirna Sequencing And Assay Market Overview
2.1. Mirna Sequencing And Assay Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Mirna Sequencing And Assay Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Mirna Sequencing And Assay Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Mirna Sequencing And Assay Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ million)
5.2. Mirna Sequencing And Assay Market Analysis By Product, 2025-2034
5.2.1. Sequencing Consumables
5.2.2. Library Preparation Kits
5.2.3. Sequencing Platforms / Instruments
5.2.4. Bioinformatics Pipelines & Services
5.3. Mirna Sequencing And Assay Market Analysis By Application, 2025-2034
5.3.1. Oncology Diagnostics / Liquid Biopsy
5.3.2. Drug Discovery & Transcriptome Research
5.3.3. Other Applications
5.4. Mirna Sequencing And Assay Market Analysis By Technology, 2025-2034
5.4.1. Sequencing by Synthesis (SBS)
5.4.2. Ion Semiconductor
5.4.3. SOLiD
5.4.4. Nanopore Sequencing
5.4.5. Single-Molecule Real-Time (SMRT)
5.5. Mirna Sequencing And Assay Market Analysis By End User, 2025-2034
5.5.1. Clinical Laboratories
5.5.2. Academic & Research Institutes
5.5.3. Biotech / Pharma Companies
5.5.4. Contract Research Organizations
6. North America Mirna Sequencing And Assay Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Mirna Sequencing And Assay Market Analysis By Product
6.3. North America Mirna Sequencing And Assay Market Analysis By Application
6.4. North America Mirna Sequencing And Assay Market Analysis By Technology
6.5. North America Mirna Sequencing And Assay Market Analysis By End User
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe Mirna Sequencing And Assay Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Mirna Sequencing And Assay Market Analysis By Product
7.3. Europe Mirna Sequencing And Assay Market Analysis By Application
7.4. Europe Mirna Sequencing And Assay Market Analysis By Technology
7.5. Europe Mirna Sequencing And Assay Market Analysis By End User
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific Mirna Sequencing And Assay Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Mirna Sequencing And Assay Market Analysis By Product
8.3. Asia-Pacific Mirna Sequencing And Assay Market Analysis By Application
8.4. Asia-Pacific Mirna Sequencing And Assay Market Analysis By Technology
8.5. Asia-Pacific Mirna Sequencing And Assay Market Analysis By End User
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa Mirna Sequencing And Assay Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Mirna Sequencing And Assay Market Analysis By Product
9.3. Middle East and Africa Mirna Sequencing And Assay Market Analysis By Application
9.4. Middle East and Africa Mirna Sequencing And Assay Market Analysis By Technology
9.5. Middle East and Africa Mirna Sequencing And Assay Market Analysis By End User
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America Mirna Sequencing And Assay Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Mirna Sequencing And Assay Market Analysis By Product
10.3. South and Central America Mirna Sequencing And Assay Market Analysis By Application
10.4. South and Central America Mirna Sequencing And Assay Market Analysis By Technology
10.5. South and Central America Mirna Sequencing And Assay Market Analysis By End User
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. Mirna Sequencing And Assay Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Illumina
11.2.2. Thermo Fisher Scientific
11.2.3. QIAGEN
11.2.4. Agilent Technologies
11.2.5. Takara Bio
11.2.6. Bio-Rad Laboratories
11.2.7. PerkinElmer
11.2.8. Merck KGaA
11.2.9. New England Biolabs
11.2.10. Lexogen
11.2.11. NanoString Technologies
11.2.12. HTG Molecular Diagnostics
11.2.13. GenXPro
11.2.14. Norgen Biotek
11.2.15. Abcam
11.2.16. Promega
11.2.17. OriGene
11.2.18. LGC Biosearch Technologies
11.2.19. System Biosciences
11.2.20. BioVendor
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Illumina
  • Thermo Fisher Scientific
  • QIAGEN
  • Agilent Technologies
  • Takara Bio
  • Bio-Rad Laboratories
  • PerkinElmer
  • Merck KGaA
  • New England Biolabs
  • Lexogen
  • NanoString Technologies
  • HTG Molecular Diagnostics
  • GenXPro
  • Norgen Biotek
  • Abcam
  • Promega
  • OriGene
  • LGC Biosearch Technologies
  • System Biosciences
  • BioVendor

Table Information